Wednesday, April 14, 2010

Coenzyme Q10-responsive ataxia: 2-Year-treatment follow-up

Movement Disorders,  Volume 9999, Issue 9999 , PagesNA -(Articles online in advance of print)
DOI. 10.1002/mds.23129


Merce Pineda, MD, PhD 1 2, Raquel Montero, PhD 2 3, Asuncion Aracil, MD 1 2, Mar M. O'Callaghan, MD 1 2, Ana Mas, MD 4, Carmen Espinos, PhD 2, Dolores Martinez-Rubio, BS 2 5, Francesc Palau, MD, PhD 2 5, Placido Navas, PhD 2 6, Paz Briones, PhD 2 7, Rafael Artuch, MD, PhD 2 3 *1Department of Pediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain
2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Spain
3Department of Clinical Biochemistry, Hospital Sant Joan de Déu, Barcelona, Spain
4Department of Pharmacy, Hospital Sant Joan de Déu, Barcelona, Spain
5Genetics and Medicine Molecular Unit, Instituto de Biomedicina de Valencia-CSIC, Valencia, Spain
6Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide, Sevilla, Spain
7Institut de Bioquímica Clínica, Hospital Clinic and CSIC, Barcelona, Spain

email: Rafael Artuch (rartuch@hsjdbcn.org)*Correspondence to Rafael Artuch, Department of Clinical Biochemistry, Hospital Sant Joan de Déu, Passeig Sant Joan de Déu, 2, 08950 Esplugues, Barcelona, Spain

KEYWORDS: coenzyme Q10 deficiency • mitochondrial disorders • ataxia • cerebellum • pediatric patients

No comments:

Post a Comment